Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masayoshi Harigai

Showing results (81-90 of 309) with videos related to

Pageof 31
Sort By:
Arthritis and Rheumatism|January 20, 2004
Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptorsYasushi Kawaguchi, Kae Takagi, Masako Hara, et al.
Modern Rheumatology|October 14, 2011
Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patientsTakao Koike, Masayoshi Harigai, Naoki Ishiguro, et al.
Modern Rheumatology|January 17, 2018
Efficacy and safety of sirukumab in Japanese patients with moderate to severe rheumatoid arthritis inadequately controlled by disease modifying anti-rheumatic drugs: Subgroup analysis of a phase 3 studyTsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka, et al.
Osteoporosis and Sarcopenia|July 28, 2020
Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort studyMasanori Nakayama, Takefumi Furuya, Eisuke Inoue, et al.
Rheumatology and Therapy|July 17, 2024
Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient RegistryMasayoshi Harigai, Eiichi Tanaka, Eisuke Inoue, et al.
International Journal of Rheumatic Diseases|June 26, 2026
Retention Rates of Biological Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Reduced Kidney Function: Analysis From the IORRA CohortTomoaki Higuchi, Eiichi Tanaka, Eisuke Inoue, et al.
Modern Rheumatology|September 12, 2022
Association between patient-reported outcomes and impairments in work and activity in patients with rheumatoid arthritis in clinical remission: A retrospective analysis using the IORRA databaseRyoko Sakai, Eiichi Tanaka, Eisuke Inoue, et al.
Rheumatology (Oxford, England)|October 10, 2014
Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE)Takahiko Sugihara, Tatsuro Ishizaki, Tadashi Hosoya, et al.
Modern Rheumatology|February 4, 2023
Nationwide clinical and epidemiological study of large-vessel vasculitis in Japan in 2017Naoko Konda, Ryoko Sakai, Keigo Saeki, et al.
Modern Rheumatology|March 6, 2024
Systematic review for the treatment of older rheumatoid arthritis patients informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritisTakahiko Sugihara, Yutaka Kawahito, Yuko Kaneko, et al.
Pageof 31

Showing results (81-90 of 309) with videos related to

Sort By:
Pageof 31
Arthritis and Rheumatism|January 20, 2004
Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptorsYasushi Kawaguchi, Kae Takagi, Masako Hara, et al.
Modern Rheumatology|October 14, 2011
Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: postmarketing surveillance report of the first 3,000 patientsTakao Koike, Masayoshi Harigai, Naoki Ishiguro, et al.
Modern Rheumatology|January 17, 2018
Efficacy and safety of sirukumab in Japanese patients with moderate to severe rheumatoid arthritis inadequately controlled by disease modifying anti-rheumatic drugs: Subgroup analysis of a phase 3 studyTsutomu Takeuchi, Yoshiya Tanaka, Hisashi Yamanaka, et al.
Osteoporosis and Sarcopenia|July 28, 2020
Factors associated with osteoporosis medication use in Japanese patients with rheumatoid arthritis: Results from the Institute of Rheumatology Rheumatoid Arthritis cohort studyMasanori Nakayama, Takefumi Furuya, Eisuke Inoue, et al.
Rheumatology and Therapy|July 17, 2024
Incidence of Malignancies and the Association with Biological Disease-Modifying Antirheumatic Drugs in Japanese Patients with Rheumatoid Arthritis: A Time-Dependent Analysis from the IORRA Patient RegistryMasayoshi Harigai, Eiichi Tanaka, Eisuke Inoue, et al.
International Journal of Rheumatic Diseases|June 26, 2026
Retention Rates of Biological Disease-Modifying Antirheumatic Drugs in Patients With Rheumatoid Arthritis and Reduced Kidney Function: Analysis From the IORRA CohortTomoaki Higuchi, Eiichi Tanaka, Eisuke Inoue, et al.
Modern Rheumatology|September 12, 2022
Association between patient-reported outcomes and impairments in work and activity in patients with rheumatoid arthritis in clinical remission: A retrospective analysis using the IORRA databaseRyoko Sakai, Eiichi Tanaka, Eisuke Inoue, et al.
Rheumatology (Oxford, England)|October 10, 2014
Structural and functional outcomes of a therapeutic strategy targeting low disease activity in patients with elderly-onset rheumatoid arthritis: a prospective cohort study (CRANE)Takahiko Sugihara, Tatsuro Ishizaki, Tadashi Hosoya, et al.
Modern Rheumatology|February 4, 2023
Nationwide clinical and epidemiological study of large-vessel vasculitis in Japan in 2017Naoko Konda, Ryoko Sakai, Keigo Saeki, et al.
Modern Rheumatology|March 6, 2024
Systematic review for the treatment of older rheumatoid arthritis patients informing the 2024 update of the Japan College of Rheumatology clinical practice guidelines for the management of rheumatoid arthritisTakahiko Sugihara, Yutaka Kawahito, Yuko Kaneko, et al.
Pageof 31